JPRN-jRCT2080223883已完成2 期
Phase II study of M518101 in patients with verruca vulgaris
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 84
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 <= 65age old（—）
- 性别
- All
入选标准
- •Patients with verruca vulgaris patients
排除标准
- •1) Patients who have a history or presence of serious drug hyper sensitivity
- •2) Patients who have cardiac, hepatic, renal, pulmonary, blood disease considered inappropriate for participation in clinical trials
- •3) Patients with immunosuppression
研究者
相似试验
未知
2 期
A Phase 2b study of M512101 in acne vulgaris for 12weeksAcne vulgarisJPRN-jRCT2080221363Maruho Co.,Ltd.
未知
3 期
A phase III long term study of M605101 in acne vulgaris patientsAcne vulgarisJPRN-jRCT2080221864Maruho Co.,Ltd.
未知
3 期
A phase II/III study of M605101 in acne vulgaris patientsAcne vulgarisJPRN-jRCT2080221742Maruho Co.,Ltd.
未知
2 期
A phase 2b study of M108101 in acne vulgaris patientsAcne vulgarisJPRN-jRCT2080221392Maruho Co.,Ltd.
未知
2 期
A Phase 2/3 Study of S-524101 in the Patients with Perennial Allergic RhinitisAllergic rhinitisJPRN-jRCT2080221872SHIONOGI & CO., LTD.